December 15, 2024 00:54 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days

Strides Pharma receives USFDA approval for Triamcinolone Acetonide Ointment USP, 0.05%

Jun 03, 2020, at 08:26 pm

Bengaluru/IBNS: Strides Pharma Science Limited (Strides) announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Triamcinolone Acetonide Ointment USP, 0.05% from the United States Food & Drug Administration (USFDA).

Strides annonces that it commenced export of Favipiravir Antiviral Tablets developed by it

May 01, 2020, at 02:55 pm

Kolkata/IBNS: Strides Pharma Science Limited (Strides), a global pharmaceutical company, has announced that it has developed and commercialized Favipiravir Antiviral tablets.

Bengaluru-based Strides Consumer forays into eastern India with two new products

Feb 05, 2020, at 04:29 pm

Kolkata/IBNS: Bengaluru-based consumer health care company, Strides Consumer Private Limited (SCPL), recently entered the market in eastern India with two new products.

Dr. R Ananthanarayanan takes over as CEO and MD of Strides Pharma from founder Arun Kumar

Jan 09, 2020, at 03:52 pm

Kolkata/IBNS: Strides Pharma Science Limited (Strides) announced  the appointment of Dr. R Ananthanarayanan as Chief Executive Officer (CEO) and Managing Director (MD) of of the company, effective January 9, 2020.